New Blood Test Detects Brain Cancer in One Hour, But Specificity Remains Limited

Among the most feared diagnoses in medicine, glioblastoma has long demanded invasive confirmation through surgical biopsy—a process as burdensome as the disease itself. Researchers from the University of Notre Dame and Australian institutions have now demonstrated that a few drops of blood, processed through a two-dollar biochip in under an hour, can detect the molecular signatures of this aggressive brain cancer with remarkable accuracy. The achievement does not yet replace the full diagnostic journey, but it opens a quieter, less violent door into early detection—one that science is only beg